Fluconazole Tablet
Product Images NDC 65862-058

7 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluconazole (NDC 65862-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Directions (Fluconazole Fig1)

Directions (Fluconazole Fig1)
An instructional illustration showing a person holding a tablet near their mouth, indicating the action of swallowing a tablet. Text below the image reads: 'Directions: Push tablet through foil and take by mouth.' This demonstrates how to remove the tablet from foil packaging for oral administration.*
FDA Label Image

Package Label-principal Display Panel (50 mg (30 Tablet Bottle))

Package Label-principal Display Panel (50 mg (30 Tablet Bottle))
Label for Fluconazole Tablets USP 50 mg, containing 30 tablets, distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dosage note to see package insert, and indicates the product is made in India. NDC 65862-058-30 is visible along with a barcode and branding of Aurobindo.*
FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))
Label for Fluconazole Tablets USP 100 mg by Aurobindo Pharma Limited, containing 30 tablets. The label states the product is Rx only and includes directions to see the package insert for full prescribing information. It provides storage instructions and distributor information for Aurobindo Pharma USA, Inc., with a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (150 mg Catch Cover (1 Card x 1 Tablet))

Package Label-principal Display Panel (150 mg Catch Cover (1 Card x 1 Tablet))
Packaging label for Fluconazole Tablet USP 150 mg by Aurobindo Pharma Limited. The label indicates it is for oral use, containing 1 tablet per card. It highlights use for vaginal yeast infections and specifies prescription-only status. Directions for use and storage conditions are included, with a peelable panel for additional information.*
FDA Label Image

Package Label-principal Display Panel (150 mg Blister Carton (12 Cards x 1 Tablet))

Package Label-principal Display Panel (150 mg Blister Carton (12 Cards x 1 Tablet))
Packaging label for Fluconazole Tablet USP 150 mg by Aurobindo Pharma Limited. The label highlights that the drug is for oral use targeting vaginal yeast infections, states 'Rx only,' and includes packaging details indicating 12 cards with 1 tablet each. It features the Aurobindo logo and includes storage instructions, lot and revision information, and a barcode.*
FDA Label Image

Package Label-principal Display Panel (200 mg (30 Tablet Bottle))

Package Label-principal Display Panel (200 mg (30 Tablet Bottle))
Label for Fluconazole Tablets USP 200 mg in tablet form from Aurobindo Pharma Limited. The label includes dosage strength, quantity of 30 tablets, storage instructions, and distributor information for Aurobindo Pharma USA, Inc. It also notes manufacturing in India and provides an NDC code 65862-061-30.*
FDA Label Image

Chemical Structure (Fluconazole Str)

Chemical Structure (Fluconazole Str)
Chemical structure of Fluconazole. The diagram shows the molecular structure including triazole rings and a difluorophenyl group characteristic of fluconazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.